Page 10 - Ipo Gmp

Park Medi World IPO opens Dec 10: GMP at 20%; 5 key risks you should know

The unlisted shares of Park Medi World were trading at ₹193 in the grey market, commanding a premium of ₹33 or 20 per cent from the upper end price of ₹162

Corona Remedies IPO off to a lukewarm start; GMP holds steady at 27%

Corona Remedies IPO: Check price band, lot size GMP, subscription status, reviews, and other key details here

Subscribed to Aequs IPO? Here's how to check allotment status, latest GMP

Once the allotment is finalised, investors who applied for the public offering can check their status on the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue

Wakefit Innovations IPO opens today: Check GMP, price band, dates, review

Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5

Meesho IPO subscribed 79x; check allotment status, GMP, listing date

Meesho IPO allotment: Applicants can verify their status through the NSE and BSE websites or by visiting the IPO registrar, Kfin Technologies

Last day to bid for Vidya Wires IPO: Check subscription status, GMP

Investors placed bids for 969 million shares in the Vidya Wires IPO, compared with the 43.33 million shares available, translating to a subscription level of 22.35 times

Last day! Aequs IPO closes today; subscription rises 28x, GMP at 37%

Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times

Final hours! Heavy NII, retail bidding boosts Meesho IPO; GMP holds steady

Meesho IPO Day 3: Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Retail investors drive demand for Aequs IPO on Day 1, NIIs follow; QIBs lag

Retail investors have oversubscribed their reserved portion by 6.42 times, while non-institutional investors (NIIs) have closely followed, with their segment oversubscribed by 1.45 times

Vidya Wires IPO fully subscribed: Retail investors lead demand; GMP at 12%

Vidya Wires IPO Day 1 update: Retail individual investors (RIIs) led the response, subscribing to their allocated portion 1.86 times

Corona Remedies IPO price band at ₹1,008-1,062; check dates, GMP, objective

Corona Remedies aims to raise ₹655.37 crore through an offer for sale of 6.2 million equity shares

Meesho IPO opens: From price band to GMP, here's all you need to know

Meesho IPO opens today: Check price band, lot size, GMP, review, allotment date, listing date and other key details here

Aequs IPO opens December 3; should you bid? Check GMP, price band here

Aequs IPO to open on December 3, 2025: Aequs plans to use the IPO proceeds for a mix of debt reduction and business expansion.

Willing to apply for Meesho IPO? Check these key risks, strengths from RHP

Investors willing to apply for Meesho IPO can review the company's strengths and risks as outlined in its Red Herring Prospectus (RHP)

Vidya Wires IPO opens tomorrow: Bid or skip? Here's what experts suggest

The unlisted shares of Vidya Wires were trading at ₹57, commanding a grey market premium of ₹5 or 9.6 per cent on Tuesday

Wakefit sets IPO price band at ₹185-195; check key dates, GMP, objective

Wakefit Innonvation aims to raise ₹1,288 crore through a fresh issue of 19.3 million shares, amounting to ₹377.18 crore, and an OFS of 46.8 million shares, amounting to ₹911.7 crore

Meesho IPO opens Dec 3: Analysts recommend long-term buy; should you bid?

Analysts at SBI Securities and Arihant Capital have recommended that investors subscribe to the Meesho IPO with a long-term perspective.

Ravelcare IPO booked 7x on Day 1; strong retail demand, GMP at 40%

Ravelcare IPO received bids for 9.22 million equity shares compared to the issue size of 1.32 million shares